Advances in PCI over the past decade mean the procedure can now approximate results only previously achieved with open-heart bypass surgery, new data show.
Just as effective as the high dose, low-dose apixaban prevents long-term recurrent venous thromboembolism in patients with ...
A show of hands at the ACC town hall demonstrated unity as specialists investigate options for a new certifying board outside the current one or with two parent sponsors.
Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...
The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...
A comprehensive literature review was conducted for all medications on the formulary of Bedlam Clinic, a free evening clinic for the medically indigent or working poor, offered by the University ...
The addition of the aldosterone synthase inhibitor helped lower blood pressure in patients with resistant hypertension.
A Northwestern medical student has found a better way of measuring someone's heart health by smartwatch using a formula of ...
The US Food and Drug Administration has approved fitusiran for bleeding prophylaxis in hemophilia A and B with or without ...
Dr. Christopher J. Sayed shares insights on the growing emphasis on personalized care for hidradenitis suppurativa.
The EMA’s Committee for Medicinal Products for Human Use said that a phase 3 study in children aged 3-14 years demonstrated ...
The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback